检索结果 - Nobutaka Nishimura
- Showing 1 - 2 results of 2
-
1
Probiotics enhances anti‐tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer 由 Makito Miyake, Yuki Oda, Takuya Owari, Kota Iida, Sayuri Ohnishi, Tomomi Fujii, Nobutaka Nishimura, Tatsuki Miyamoto, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
出版 2022Artigo -
2
Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma 由 Nobutaka Nishimura, Makito Miyake, Norimi Takamatsu, Kosuke Mieda, Kuniaki Inoue, Akira Tachibana, Keichi Sakamoto, Mikiko Onishi, Fumisato Maesaka, Takanosuke Yoshikawa, Mitsuru Tomizawa, Takuto Shimizu, Kenta Onishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
出版 2025Artigo
相关主题
Cancer
Chemotherapy
Internal medicine
Medicine
Avelumab
Bacteria
Bifidobacterium
Bifidobacterium breve
Biology
Bladder cancer
Cancer research
Gemcitabine
Genetics
Gut flora
Immune system
Immunology
Immunotherapy
Lactobacillus
Maintenance therapy
Metastatic Urothelial Carcinoma
Oncology
Pembrolizumab
Tumor microenvironment
Urothelial carcinoma